PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Published 2017 View Full Article

Authors

Keywords

PD-L1; TKI; YAP1; NSCLC

Journal

Oncotarget

Volume 9, Issue 4, Pages -

Publisher

Impact Journals, LLC

Online

2017-12-13

DOI

10.18632/oncotarget.23161

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started